Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Oocyte donation in patients without ovarian function.

P Devroey1, A Wisanto, M Camus

  • 1Centre for Reproductive Medicine, Universiteit Brussel, Belgium.

Human Reproduction (Oxford, England)
|August 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oral dydrogesterone versus micronized vaginal progesterone for luteal phase support: a double-blind crossover study investigating pharmacokinetics and impact on the endometrium.

Human reproduction (Oxford, England)·2023
Same author

The proliferative phase endometrium in IVF/ICSI: an in-cycle molecular analysis predictive of the outcome following fresh embryo transfer.

Human reproduction (Oxford, England)·2020
Same author

Squamous cell carcinoma in situ lining the uterine cavity.

European journal of gynaecological oncology·2016
Same author

Paratesticular leiomyoma in an azoospermic patient and -successful testicular sperm extraction (TESE) for intracytoplasmic sperm injection (ICSI) with an ongoing pregnancy.

Facts, views & vision in ObGyn·2014
Same author

Impact of clomiphene citrate during ovarian stimulation on the luteal phase after GnRH agonist trigger.

Reproductive biomedicine online·2014
Same author

Endometrial gene expression in the early luteal phase is impacted by mode of triggering final oocyte maturation in recFSH stimulated and GnRH antagonist co-treated IVF cycles.

Human reproduction (Oxford, England)·2012
Same journal

Characterizing endometriosis and adenomyosis symptom clusters and their impact on quality of life in the All of Us Research Program.

Human reproduction (Oxford, England)·2026
Same journal

A new regulatory framework: impact of the SoHO Regulation for medically assisted reproduction.

Human reproduction (Oxford, England)·2026
Same journal

Subfertility in relation to gestational weight gain and gestational diabetes: the Norwegian Mother, Father and Child Cohort Study.

Human reproduction (Oxford, England)·2026
Same journal

Pathogenic variants in ACTRT3 lead to male infertility characterized by fertilization defects.

Human reproduction (Oxford, England)·2026
Same journal

A large retrospective study on 1PN embryo transfer supports the need for updated harmonized best practice guidelines.

Human reproduction (Oxford, England)·2026
Same journal

Explainability of artificial intelligence (AI) tools in assisted reproductive technologies (ARTs): promise, clinical reality, and conceptual limits.

Human reproduction (Oxford, England)·2026
See all related articles

This study investigated primary ovarian failure in women undergoing oocyte donation. Successful pregnancies were achieved through hormone therapy, highlighting the viability of assisted reproduction in these cases.

Area of Science:

  • Reproductive Endocrinology
  • Genetics
  • Obstetrics

Background:

  • Primary ovarian failure (POF) affects numerous women of reproductive age.
  • Understanding the diverse etiologies of POF is crucial for effective management.
  • Oocyte donation offers a pathway to pregnancy for women with POF.

Purpose of the Study:

  • To report clinical, hormonal, and cytogenetic findings in women with POF referred for oocyte or embryo donation.
  • To evaluate the safety and efficacy of assisted reproductive technologies in this cohort.
  • To assess obstetric risks associated with specific genetic abnormalities.

Main Methods:

  • Retrospective analysis of 36 women with primary ovarian failure.
  • Clinical evaluation, hormonal assays (serum gonadotrophins), and cytogenetic analysis.

Related Experiment Videos

  • Hysterosalpingography and ovarian biopsies were performed in select cases.
  • Hormone substitution therapy (oestradiol valerate and natural progesterone) was administered.

    • Main Results:

    • Etiologies included ovarian dysgenesis (15), premature menopause (11), X-chromosome abnormalities (6), Noonan syndrome (1), and surgical menopause (10).
    • All patients exhibited menopausal range serum gonadotrophins; hypothalamic-pituitary-thyroid function was normal.
    • Primordial follicles were identified in one ovarian biopsy.
    • Thirteen pregnancies were established, resulting in eight live births (including twins) and three ongoing pregnancies.
    • Obstetric risk assessment was critical for patients with X-chromosome aberrations and Noonan syndrome.

    Conclusions:

    • Oocyte donation is a viable option for women with primary ovarian failure.
    • Hormone substitution therapy can facilitate successful pregnancies.
    • Careful pre-donation assessment, including cytogenetic evaluation, is essential for managing obstetric risks.